Immunocompromised individuals not expected to mount an adequate immune response to COVID-19 vaccination or SARS-CoV-2 infection due to their underlying conditions, regardless of vaccine status (see Immunocompromising Conditions below); or Unvaccinated individuals at the highest risk of severe disease (anyone aged ≥75 years or anyone aged ≥65 years with additional risk factors).
Should we have a larger allocation to distribute in the future, we will consider further prioritization of courses. Please understand that even those in this highest risk category may not receive their prescription due to the limited availability of product and may not be eligible by the time the next allocation is available. The federal government is working hard to obtain as much oral therapy as possible at this time.
In settings, such as confinement facilities or other congregate care settings, where the ability to access these medications is limited, please reach out to [email protected] or your local health department to determine if courses may be available through other sources, such at a local pharmacy or
health center that could be deployed to your facility .